To develop an ergonomic behind-the-ear device, to increase speech clarity in patients with Parkinson’s disease.


Working closely with the SpeechVive team, Pulse worked on the design of both the wearable unit and its case, always mindful of the inherent physical limitations of the end user.


The clinical trial conclusively demonstrated SpeechVive™ was effective in improving speech clarity for mild, moderate and severe PD progression, while existing therapies are only effective in patients with mild symptoms.


A 20 patient clinical trial with the commercially available SpeechVive™ device took place at Purdue University, James Madison University, and University of Florida in November 2012 and commercial sales launched in 2013.